However, as research progressed, its therapeutic potential expanded beyond gastrointestinal applications
If you're recovering from an injury, dealing with chronic joint pain, or looking for a way to accelerate healing after surgery, you may have heard about BPC-157
What the Research Record Shows The BPC-157 literature is extensive for an unapproved compound and concentrated: the overwhelming majority of published work originates from a single research group at the University of Zagreb, led by Predrag Sikiric and Sven Seiwerth [11]
GHK-Cu: A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) with broad regenerative activity
Call (702) 808-2650 or text us to book
(In reality, Bidens FDA had declared the medications unproven and potentially dangerous, and put a halt on production of many peptides until more research was complete.) But, Kennedy teased in the February podcast, things may be changing